Trifluridine / tipiracil (FTd / TPI, TAS-102) in the treatment of patients with metastatic colon cancer: from preclinical experiments to routine clinical practice

od M. Yu. Fedyanin
Wydane 2020-12-01

Practical recommendation for treatment of patients with colon cancer during covid-19 pandemic

od M. Yu. Fedyanin
Wydane 2020-07-01

Aflibercept: side effects in focus

od M. Yu. Fedyanin
Wydane 2018-07-01

Metronomic chemotherapy regimens in oncology

od M. Yu. Fedyanin, I. A. Pokataev, S. A. Tyulyandin
Wydane 2016-04-01

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2015-02-01

Localization of the primary tumor of the colon: аre there essential differences?

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2017-12-01

Role of microsatellite instability in colon cancer

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2015-02-01

CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2015-05-01

Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer?

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tyulyandin
Wydane 2015-10-01

FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2015-02-01

Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2018-07-01

PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2015-02-01

Chemotherapy of metastatic colon cancer

od M. Yu. Fedyanin, A. А. Tryakin, S. A. Tjulandin
Wydane 2015-02-01

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY

od M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2015-02-01

The role of circulating tumor DNA in patients with colon cancer

od M. Yu. Fedyanin, E. M. Polyanskaya, S. A. Tjulyandin
Wydane 2016-10-01

Heterogeneity and clonal evolution of colorectal cancer

od M. Yu. Fedyanin, H. H.-M. Elsnukaeva, S. A. Tjulandin
Wydane 2017-04-01

Colorectal cancer, screening: achievements и opportunities

od E. A. Polyanskaya, M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Wydane 2018-12-01

Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer

od M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. A. Tyulyandin
Wydane 2017-04-01

Prospects of therapeutic action on FGFR signaling pathway

od M. Yu. Fedyanin, D. N. Khmelkova, T. S. Serebriyskaya, T. A. Nikolskaya, S. A. Tyulyandin
Wydane 2015-06-01

Some aspects of immunotherapy in colon cancer

od M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, A. A. Tryakin, S. A. Tyulyandin
Wydane 2018-05-01